investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Inhibiting oncogenic kinases to target metabolism in AML

Aaron David Schimmer

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)

Related projects

Dharmendra Dingar

In vivo BioID identifies novel c-MYC interacting partners

Leukaemia

Peter Stirling

Mechanisms of genome instability induced by RNA splicing defects

Leukaemia

Linda Ya-Ting Chang

Role of innate immune signaling in myelodysplastic syndromes

Leukaemia

Hanyang Lin

Identification of new microRNA biomarkers and candidate target genes in primitive CML cells using global comparative RNA analyses

Leukaemia

Inanc Birol

High throughput analysis of RNA-seq reads to characterize alternative polyadenylation in myeloid malignancy

Leukaemia

Peter Aplan

Collaborative Pathways that Lead to Leukemia

Leukaemia

Pathology Hematology and hematologic malignancies

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Pathology Hematology and hematologic malignancies

Catherine Jenkins

Oncogenic collaboration between RUNX and Notch in T-cell leukemia

Leukaemia

Aaron David Schimmer

Targeting mitochondrial translation as a novel therapeutic strategy for AML

Leukaemia